"10.1371_journal.pone.0041341","plos one","2012-07-19T00:00:00Z","Mathias Gehrmann; Stefan Stangl; Andreas Kirschner; Gemma A Foulds; Wolfgang Sievert; Brigitte T Doß; Axel Walch; Alan G Pockley; Gabriele Multhoff","Department of Radiation Oncology, Klinikum rechts der Isar, Technische Universität München, and Clinical Cooperation Group (CCG) Innate Immunity in Tumor Biology, Helmholtz Zentrum München, Deutsches Forschungszentrum für Gesundheit und Umwelt, Munich, Germany; Department of Oncology, The Medical School, University of Sheffield, Sheffield, United Kingdom; Institute of Pathology, Helmholtz Zentrum München, Deutsches Forschungszentrum für Gesundheit und Umwelt, Munich, Germany","Conceived and designed the experiments: GM. Performed the experiments: SS AK GAF WS BTD. Analyzed the data: AW AGP GM. Contributed reagents/materials/analysis tools: AW. Wrote the paper: GM.","Gabriele Multhoff and Alan Graham Pockley serve as Academic Editors of PLoS ONE. This study was partly funded by multimmune GmbH. The membrane Hsp70 phenotype on viable tumor and metastatic cells of patients was determined by flow cytometry using FITC-conjugated cmHsp70.1 mAb (multimmune GmbH, Germany). There are no other patents, products in development or marketed products to declare. This does not alter the authors adherence to all the PLoS ONE policies on sharing data and materials, as detailed online in the guide for authors.","2012","07","Mathias Gehrmann","MG",9,TRUE,1,5,3,1,FALSE,FALSE,TRUE,1,"1",TRUE
